Atomera Q2 Loss Widens to $6.3M; Cash at $38.4M After $23.6M Direct Offering

summarizeSummary

Atomera's Q2 net loss widened to $6.3 million on minimal revenue, with operating expenses climbing sharply. Cash reserves stand at $38.4 million after a recent direct offering, and the authorized share count has been doubled to 95 million.

check_boxKey Events · Earnings and Guidance · ATOM

• Q2 Net Loss Widens

  Net loss increased to $6.3 million from $5.0 million in Q2 2025, as operating expenses rose 33% to $6.9 million, primarily from higher G&A and R&D costs.

• Cash Runway Extended

  Cash and short-term investments totaled $38.4 million at June 30, 2026, following a $23.6 million direct offering in February. Management believes this funds operations for at least 12 months.

• Authorized Shares Doubled

  A May 2026 amendment increased authorized common shares from 47.5 million to 95 million, providing capacity for future equity raises but also significant potential dilution.

• ATM Activity Paused

  No shares were sold under the 2025 at-the-market program during Q2 2026, after selling 1.3 million shares at an average $2.47 in the first half of the year.

auto_awesomeAnalysis · ATOM · Manufacturing

A 33% jump in operating expenses to $6.9 million pushed Atomera's Q2 net loss to $6.3 million, up from $5.0 million a year ago. Revenue remains negligible at $158,000. The quarter ended with $38.4 million in cash and short-term investments, thanks to a $23.6 million direct offering in February—enough, management says, to fund operations for at least 12 months. The filing also reflects a May 2026 amendment that doubled authorized common shares to 95 million, creating headroom for future capital raises but also the potential for dilution.